Go Pro

Privia Health Group (PRVA) Competitors

Privia Health Group logo
$27.49 -0.28 (-1.01%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$27.49 0.00 (0.00%)
As of 07/10/2026 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PRVA vs. BTSG, FMS, HIMS, PACS, and CELC

Should you buy Privia Health Group stock or one of its competitors? MarketBeat compares Privia Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Privia Health Group include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does Privia Health Group compare to BrightSpring Health Services?

Privia Health Group (NASDAQ:PRVA) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

BrightSpring Health Services has a net margin of 2.27% compared to Privia Health Group's net margin of 0.97%. BrightSpring Health Services' return on equity of 14.63% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group0.97% 2.81% 1.61%
BrightSpring Health Services 2.27%14.63%4.41%

BrightSpring Health Services has higher revenue and earnings than Privia Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$2.12B1.63$22.92M$0.16171.81
BrightSpring Health Services$12.91B1.09$190.67M$1.4150.66

Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market.

In the previous week, Privia Health Group had 6 more articles in the media than BrightSpring Health Services. MarketBeat recorded 17 mentions for Privia Health Group and 11 mentions for BrightSpring Health Services. Privia Health Group's average media sentiment score of 0.10 beat BrightSpring Health Services' score of 0.04 indicating that Privia Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
5 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BrightSpring Health Services
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

94.5% of Privia Health Group shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Privia Health Group presently has a consensus price target of $31.15, indicating a potential upside of 13.33%. BrightSpring Health Services has a consensus price target of $66.56, indicating a potential downside of 6.81%. Given Privia Health Group's higher probable upside, equities research analysts clearly believe Privia Health Group is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
17 Buy rating(s)
1 Strong Buy rating(s)
3.00

Summary

BrightSpring Health Services beats Privia Health Group on 10 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Privia Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.65
Privia Health Group$2.12B1.63$22.92M$0.16171.81

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Privia Health Group's net margin of 0.97%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Privia Health Group 0.97%2.81%1.61%

Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, suggesting a potential upside of 16.52%. Privia Health Group has a consensus price target of $31.15, suggesting a potential upside of 13.33%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Privia Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.56
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, Privia Health Group had 14 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 17 mentions for Privia Health Group and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.64 beat Privia Health Group's score of 0.10 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Privia Health Group
5 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Fresenius Medical Care AG & Co. KGaA and Privia Health Group tied by winning 8 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Privia Health Group has a net margin of 0.97% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group0.97% 2.81% 1.61%
Hims & Hers Health -0.56%6.10%1.52%

Privia Health Group has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market.

In the previous week, Privia Health Group had 7 more articles in the media than Hims & Hers Health. MarketBeat recorded 17 mentions for Privia Health Group and 10 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.80 beat Privia Health Group's score of 0.10 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
5 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hims & Hers Health
6 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Privia Health Group currently has a consensus target price of $31.15, suggesting a potential upside of 13.33%. Hims & Hers Health has a consensus target price of $30.70, suggesting a potential downside of 10.88%. Given Privia Health Group's stronger consensus rating and higher probable upside, equities analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
Hims & Hers Health
2 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.13

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$2.12B1.63$22.92M$0.16171.81
Hims & Hers Health$2.35B3.40$128.37M-$0.09N/A

Summary

Privia Health Group beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to PACS Group?

PACS Group (NYSE:PACS) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

PACS Group has higher revenue and earnings than Privia Health Group. PACS Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.29$191.54M$1.5627.72
Privia Health Group$2.12B1.63$22.92M$0.16171.81

PACS Group has a net margin of 4.49% compared to Privia Health Group's net margin of 0.97%. PACS Group's return on equity of 26.47% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Privia Health Group 0.97%2.81%1.61%

94.5% of Privia Health Group shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

PACS Group has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

In the previous week, PACS Group had 6 more articles in the media than Privia Health Group. MarketBeat recorded 23 mentions for PACS Group and 17 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.10 beat PACS Group's score of -0.07 indicating that Privia Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
7 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Privia Health Group
5 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PACS Group presently has a consensus price target of $50.60, indicating a potential upside of 17.02%. Privia Health Group has a consensus price target of $31.15, indicating a potential upside of 13.33%. Given PACS Group's higher probable upside, equities analysts plainly believe PACS Group is more favorable than Privia Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

Summary

PACS Group beats Privia Health Group on 9 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Celcuity?

Privia Health Group (NASDAQ:PRVA) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 5.7% of Privia Health Group shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Privia Health Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$2.12B1.63$22.92M$0.16171.81
CelcuityN/AN/A-$177.04M-$3.90N/A

Privia Health Group currently has a consensus target price of $31.15, indicating a potential upside of 13.33%. Celcuity has a consensus target price of $152.09, indicating a potential upside of 41.37%. Given Celcuity's stronger consensus rating and higher possible upside, analysts plainly believe Celcuity is more favorable than Privia Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83

Privia Health Group has a net margin of 0.97% compared to Celcuity's net margin of 0.00%. Privia Health Group's return on equity of 2.81% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group0.97% 2.81% 1.61%
Celcuity N/A -244.61%-50.22%

Privia Health Group has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Celcuity has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market.

In the previous week, Privia Health Group had 15 more articles in the media than Celcuity. MarketBeat recorded 17 mentions for Privia Health Group and 2 mentions for Celcuity. Celcuity's average media sentiment score of 1.88 beat Privia Health Group's score of 0.10 indicating that Celcuity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
5 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Celcuity
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Privia Health Group beats Celcuity on 10 of the 14 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRVA vs. The Competition

MetricPrivia Health GroupMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.50B$1.84B$7.14B$12.64B
Dividend YieldN/AN/A2.68%7.83%
P/E Ratio171.8276.5127.3924.58
Price / Sales1.637.39593.20121.95
Price / Cash104.0627.8249.3460.04
Price / Book4.285.6310.886.38
Net Income$22.92M-$54.76M$3.59B$331.87M
7 Day Performance0.48%1.37%-0.24%0.37%
1 Month Performance17.68%5.49%4.53%0.53%
1 Year Performance34.29%-1.21%29.19%21.96%

Privia Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRVA
Privia Health Group
3.5392 of 5 stars
$27.49
-1.0%
$31.15
+13.3%
+30.3%$3.50B$2.12B171.821,226
BTSG
BrightSpring Health Services
2.7077 of 5 stars
$68.84
-2.4%
$63.67
-7.5%
+242.4%$13.58B$12.91B48.8323,500
FMS
Fresenius Medical Care AG & Co. KGaA
4.3857 of 5 stars
$24.18
+2.4%
$28.00
+15.8%
-12.3%$12.99B$22.20B12.721,488
HIMS
Hims & Hers Health
3.0328 of 5 stars
$36.98
-3.4%
$30.63
-17.2%
-31.4%$8.56B$2.35BN/A2,442
PACS
PACS Group
3.1286 of 5 stars
$44.22
-1.7%
$48.00
+8.6%
+238.1%$7.00B$5.29B28.3547,455

Related Companies and Tools


This page (NASDAQ:PRVA) was last updated on 7/11/2026 by MarketBeat.com Staff.
From Our Partners